EE9 A Cost-Effectiveness Analysis of Abrocitinib vs. Upadacitinib and Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
Abstract
Authors
Boglarka Mikudina Gulraj S. Matharu Karim Amer Iulia Dunnett Fionn Woodcock Zenas Z. Yiu